Navigation Links
Scaling up: The future of nanoscience
Date:1/12/2011

In the late 1950s, Richard Feynman famously imagined a science where researchers and engineers could achieve remarkable feats by manipulating matter and creating structures all the way down to the level of individual atoms.

Now, over fifty years after "There's Plenty of Room at the Bottom," four prominent researchers - David Awschalom, Angela Belcher, Donald Eigler, and Michael Roukes - are sharing their thoughts about the future of nanoscience and nanotechnology. In a special dialogue ahead of a Kavli Futures Symposium on the same topic, the scientists focused on how Feyman's vision may evolve in the next fifty years, beginning with taking nanoscience in an upward direction.

"We've gained some important beachheads in the science, but we've also made very little progress towards translating this toward what we all often speak of as the "full potential" of nanotechnology," said Michael Roukes, professor of physics, applied physics and bioengineering at Caltech and co-director of the Kavli Institute of Nanoscience. "Going forward, I think the challenge is to breach this chasm and actually translate this into stuff that affects our everyday lives. [It will be about] using the building blocks of individual atoms, molecules, individual nanostructures, and assembling them into larger-scale systems with emergent functionality that will be of great use to humankind."

Roukes explained there are many things that are very exciting about being able to control things at the atomic scale and then - from the bottom - "build back to the middle to creating complex systems with just incredibly exquisite control about what these complex systems do. [O]ne area that's absolutely ripe for incredible advances is the life sciences and medicine, where aggregations of individual nanodevices to create nanosystems will allow us to embrace, rather than run away from, the complexity of biological systems."

These advances, stated Roukes, could "give
'/>"/>

Contact: James Cohen
cohen@kavlifoundation.org
The Kavli Foundation
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Scaling the wall of deafness
2. Increasing diversity of future life science researchers
3. Polar bears no longer on thin ice: researchers say polar bears could face brighter future
4. An element of concern: phosphorus, food and our future
5. National team of scientists peers into the future of stem cell biology
6. Partnership Is Game-Changer for the Future of eCommerce
7. Conditioning reefs for the future
8. Biodiversity targets for the future
9. Fall bonefish census sounds warning bell that warrants careful future monitoring
10. Hebrew University research carries cautionary warning for future stem cell applications
11. Tests show bright future for gadonanotubes in stem cell tracking
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... research, supported by the National Science Foundation (NSF), ... uniformly accelerates atmospheric warming, indicating instead that certain ... emit into the atmosphere. , The study, ... , focuses on thermokarst lakes, which occur as ... with melted fresh water, converting what was previously ...
(Date:7/31/2014)... A long-term follow-up study (HPV-023; NCT00518336) shows ... GlaxoSmithKline,s human papilloma virus (HPV) vaccine Cervarix. ... were followed for more than nine years, ... was 100%. This is the longest follow-up ... https://www.landesbioscience.com/journals/vaccines/article/29532/ for the full paper. ...
(Date:7/31/2014)... of animal models against the highly infectious and virulent ... disease that kills approximately 30,000 Americans annually. The research ... Immunity . , In the study, the vaccine ... toxins produced by C. difficile , as well ... that mimics the human disease, after only two immunizations. ...
Breaking Biology News(10 mins):Certain Arctic lakes store more greenhouse gases than they release 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 3C. difficile vaccine proves safe, 100 percent effective in animal models 2
... PA, June 24, 2011 Adolescents who diet and ... behaviors and binge eating) carry these unhealthy practices into ... by University of Minnesota researchers and published in the ... American Dietetic Association . "The findings from the ...
... are widely recognized as significant environmental concerns in the ... major impact of landscape irrigation on their regional water ... in College Station, Texas, estimated that more than 24 ... annually for landscape irrigation alone. According to the ...
... June 23, 2011 UT Southwestern Medical Center researchers ... pathway in Huntington,s disease, a finding that may eventually ... the progression of degenerative nerve disorders. "Our studies ... treatment and possibly for other neurodegenerative diseases," said Dr. ...
Cached Biology News:Adolescents' dieting and disordered eating behaviors continue into young adulthood 2Adolescents' dieting and disordered eating behaviors continue into young adulthood 3Landscape coefficients prove useful for urban water conservation efforts 2Compound may provide drug therapy approach for Huntington's disease 2
(Date:7/31/2014)... North Shore Towers, a luxury co-op community ... Energy, one of the nation’s leading combined heating and power ... its 43-year-old CHP system. The original CHP system had been ... extend the life of the plant, GI Energy was contracted ... heat recovery equipment, while maintaining continuous operation of the entire ...
(Date:7/31/2014)... SAN DIEGO, July 31, 2014 ... a leading company using proprietary taste science technologies ... for the food, beverage, and ingredient supply industries, ... 2014.  The Company ended the second quarter with ... "During the past quarter Senomyx ...
(Date:7/31/2014)... Rancho BioSciences , the scientific ... Array Suite with tranSMART . Scientists that ... send data in tranSMART to Array Suite for further ... tranSMART including the new 1.2 release. Array Suite ... for the analysis of high dimensional quantification data, including ...
(Date:7/31/2014)... BOTHELL, Wash. , July 31, 2014   ... a leading developer, manufacturer and marketer of proprietary clinical ... media and precision thermal shipping products ... Company,s second quarter 2014 financial results will be released ... will host a conference call and live webcast at ...
Breaking Biology Technology:North Shore Towers Partners with GI Energy to Install Turnkey Natural Gas-Fired Combined Heat and Power Plant 2SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 14SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 15SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 16Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 2Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 3BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014 2
... , IRVINE, Calif. , April 26 ... products chemistry company which provides novel and innovative ingredients ... announced today the launch of pTeroPure™ pterostilbene(tero-STILL-bean). This exciting ... an exclusive worldwide license to all patent rights of ...
... SAN DIEGO , April 26 ... the discovery and development of RNA-targeted therapies, today announced ... research candidate directed against PCSK9 (proprotein convertase subtilisin/kexin type ... high cholesterol. Using its proprietary Locked Nucleic Acid (LNA) ...
... 23 Asymchem Laboratories is proud to announce and welcome Dr. ... Huang as Director of Chemical Development, and Dr. Xiaojun Huang ... , , ... February 1, 2010 .  He brings extensive scientific and managerial experience in ...
Cached Biology Technology:ChromaDex Launches pTeroPure Pterostilbene 2ChromaDex Launches pTeroPure Pterostilbene 3ChromaDex Launches pTeroPure Pterostilbene 4ChromaDex Launches pTeroPure Pterostilbene 5Santaris Pharma A/S Advances RNA-Targeted Drug Development Candidate Against PCSK9, an Important New Target for the Treatment of High Cholesterol 2Santaris Pharma A/S Advances RNA-Targeted Drug Development Candidate Against PCSK9, an Important New Target for the Treatment of High Cholesterol 3Santaris Pharma A/S Advances RNA-Targeted Drug Development Candidate Against PCSK9, an Important New Target for the Treatment of High Cholesterol 4Santaris Pharma A/S Advances RNA-Targeted Drug Development Candidate Against PCSK9, an Important New Target for the Treatment of High Cholesterol 5Asymchem Laboratories Hires Three New Employees: Guojie Xu, Pingzhong Huang, and Xiaojun Huang 2
... Columns are designed for the rapid purification of ... agarose gels. The DNA band is excised from ... Embedded within the base of the column are ... agarose and impurities back while allowing DNA to ...
... Ultra Agarose Spin Kit is an advanced system for ... purified DNA can be used directly for any downstream ... DNA is ready to use in 56 minutes ... used for TAE and TBE gels No specialised ...
This depletion cocktail is tailored to deplete IgE-bearing (I.e. basophils and mast cells) from whole blood...
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human HLA-DR TAC is designed to deplete human HLA-DR from samples to isolate resting CD4+ or CD8+ T cells....
Biology Products: